Interpace Biosciences Inc (IDXG)
3.09
-0.19
(-5.79%)
USD |
OTCM |
Nov 14, 15:46
Interpace Biosciences Gross Profit Margin (Quarterly): 61.71% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 61.71% |
| March 31, 2024 | 59.10% |
| December 31, 2023 | 59.67% |
| September 30, 2023 | 54.57% |
| June 30, 2023 | 61.99% |
| March 31, 2023 | 60.84% |
| December 31, 2022 | 60.14% |
| September 30, 2022 | 57.78% |
| June 30, 2022 | 51.79% |
| March 31, 2022 | 58.79% |
| December 31, 2021 | 54.90% |
| September 30, 2021 | 55.07% |
| June 30, 2021 | 48.01% |
| March 31, 2021 | 45.94% |
| December 31, 2020 | 32.44% |
| September 30, 2020 | 37.03% |
| June 30, 2020 | 29.31% |
| March 31, 2020 | 32.52% |
| December 31, 2019 | -28.09% |
| September 30, 2019 | 37.41% |
| June 30, 2019 | 51.66% |
| March 31, 2019 | 56.37% |
| December 31, 2018 | 55.31% |
| September 30, 2018 | 51.97% |
| June 30, 2018 | 59.15% |
| Date | Value |
|---|---|
| March 31, 2018 | 46.35% |
| December 31, 2017 | 62.49% |
| September 30, 2017 | 50.76% |
| June 30, 2017 | 51.26% |
| March 31, 2017 | 48.96% |
| December 31, 2016 | 43.15% |
| September 30, 2016 | 44.33% |
| June 30, 2016 | 49.00% |
| March 31, 2016 | 61.15% |
| December 31, 2015 | 34.04% |
| September 30, 2015 | 28.21% |
| June 30, 2015 | 17.84% |
| March 31, 2015 | 25.65% |
| December 31, 2014 | 15.58% |
| September 30, 2014 | 13.64% |
| June 30, 2014 | 16.75% |
| March 31, 2014 | 16.08% |
| December 31, 2013 | 10.86% |
| September 30, 2013 | 13.71% |
| June 30, 2013 | 18.39% |
| March 31, 2013 | 19.74% |
| December 31, 2012 | 19.60% |
| September 30, 2012 | 18.69% |
| June 30, 2012 | 23.63% |
| March 31, 2012 | 23.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-28.09%
Minimum
Dec 2019
61.99%
Maximum
Jun 2023
47.03%
Average
54.90%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 40.84% |
| XWELL Inc | 33.17% |
| ProPhase Labs Inc | -19.24% |
| Applied DNA Sciences Inc | 30.75% |
| Veracyte Inc | 68.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 20.53% |
| Profit Margin (Quarterly) | 17.12% |
| Operating Margin (Quarterly) | 18.74% |
| Return on Net Operating Assets | 28.66% |